Clarametyx Biosciences Expands Board of Directors with Appointment of Financial Executive Michael Layman
Mr. Layman joins as an independent director as the company continues to…
David Richards Appointed CEO of Clarametyx Biosciences
Company also expands Board of Directors with the appointment of Larry Edwards…
Newly Published Insights in Biofilm Illustrate the Powerful Mechanisms of an Antibody Biofilm Eradication Therapy Approach
Biofilms represent a substantial challenge to treating bacterial infections,…
Data Published in Ebiomedicine Validates Novel Scientific Approach that Disarms Bacterial Defenses to Treat or Prevent Life-threatening Infections
Approach effectively degrades bacterial protective shields to enable immune or…
Clarametyx Biosciences Launches with an Ambitious Strategy to Address Life-threatening Bacterial Infections
Renowned Columbus-based leaders and scientific innovators to develop novel…